Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CINACALCET | 90MG | TABLET | Resolved | 2020-08-06 | 2021-04-01 | 121862 |
TEVA-CINACALCET | 90MG | TABLET | Resolved | 2022-06-03 | 2022-07-01 | 161937 |
TEVA-CINACALCET | 90MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-11 | 224913 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2018-09-12 | 2019-03-12 | 61343 |
TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2020-01-09 | 2020-08-21 | 102931 |
TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119883 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124956 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2021-02-25 | 2021-09-16 | 134743 |
TEVA-ONDANSETRON | 8MG | TABLET | Resolved | 2021-07-15 | 2023-04-28 | 142604 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-01-07 | 2022-03-09 | 152408 |
TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-03-04 | 2022-05-19 | 156073 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-05-19 | 2022-05-21 | 160986 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170795 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2023-06-08 | 2023-07-28 | 194113 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195475 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2023-10-26 | 2023-11-23 | 208254 |
TEVA-CANDESARTAN | 8MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211985 |
ACT ENALAPRIL | 8MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225486 |
TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |
TEVA-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120039 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |